Abstract Body

Histone deacetylase inhibitors (HDACi) induced HIV RNA, but did not reduce the latent HIV reservoir in clinical trials. Previously, we demonstrated that HDACi suberoylanilide hydroxamic acid (SAHA) had mixed effects on host gene and protein expression, some of which would be predicted to promote, and some inhibit HIV reactivation. An upregulated high mobility group A1 (HMGA1) gene encodes a protein that repressed reporter transcription from HIV LTR in cell lines (Eilebrecht et al., 2013). In the present study, we investigated 1) whether the degree of HMGA1 upregulation by SAHA correlated with levels of HIV reactivation, and 2) whether knocking down HMGA1 would improve the ability of SAHA to reactivate latent HIV.

An in vitro model was used to generate latent HIV infection in resting primary CD4 T cells from 24 different blood donors. Cells were treated for 24h with 1M SAHA or its solvent dimethyl sulfoxide (control). Expression of HIV and HMGA1 RNA was assessed by droplet digital PCR. Pearson correlation analysis between HMGA1 upregulation and HIV RNA induction was performed using 21 paired SAHA-treated and control samples. To induce HMGA1 knockdown, cells were treated for 3 days with GapmeR reagents from Exiqon, Inc. before SAHA treatment. GapmeRs contain locked nucleic acid base pairs, enter cells by gymnosis without a need for transfection, and induce stable knockdowns via target RNA degradation by RNase H. Samples from 3 blood donors were used to test whether HIV expression following SAHA treatment was greater in the samples with HMGA1 knockdown than untreated ones. Expression in SAHA-treated samples was normalized to expression in DMSO-treated samples, and a t-test was used to determine whether the difference was significant.

Fold induction of HIV RNA expression upon SAHA treatment negatively correlated with the induction in HMGA1 expression (R=-0.5, p=0.02). HIV non-responders to SAHA consistently had the greatest upregulation of HMGA1 (Fig 1). GapmeRs induced, on average, 33% knockdown (p=0.03). In the presence of GapmeRs, expression of HIV following SAHA treatment was higher than in the cells incubated in parallel in the absence of GapmeRs (fold change 2.1, p=0.09).

To our knowledge, our data are first to demonstrate a possible role of the host factor HMGA1 in HIV reactivation from latency in primary CD4 T cells. The data suggest that inhibiting HMGA1 may improve the ability of SAHA to reactivate latent HIV.